Market Closed -
Nyse
04:00:02 2024-06-14 pm EDT
|
5-day change
|
1st Jan Change
|
104
USD
|
+0.16%
|
|
+0.22%
|
+15.38%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
33,186
|
26,966
|
37,333
|
30,974
|
49,906
|
62,207
|
-
|
-
|
Enterprise Value (EV)
1 |
48,189
|
39,162
|
51,195
|
44,890
|
63,648
|
76,108
|
76,559
|
77,443
|
P/E ratio
|
26.8
x
|
27.7
x
|
110
x
|
219
x
|
137
x
|
79.7
x
|
59.7
x
|
51.3
x
|
Yield
|
4.26%
|
4.18%
|
2.84%
|
3.72%
|
2.71%
|
2.44%
|
2.53%
|
2.7%
|
Capitalization / Revenue
|
6.48
x
|
5.85
x
|
7.87
x
|
5.29
x
|
7.52
x
|
8.03
x
|
7.14
x
|
6.33
x
|
EV / Revenue
|
9.41
x
|
8.5
x
|
10.8
x
|
7.66
x
|
9.59
x
|
9.83
x
|
8.79
x
|
7.88
x
|
EV / EBITDA
|
20.9
x
|
20.8
x
|
27.8
x
|
20.9
x
|
25.3
x
|
26
x
|
22.9
x
|
21.2
x
|
EV / FCF
|
54.5
x
|
42.6
x
|
89.1
x
|
-
|
-
|
133
x
|
55.3
x
|
43.1
x
|
FCF Yield
|
1.83%
|
2.35%
|
1.12%
|
-
|
-
|
0.75%
|
1.81%
|
2.32%
|
Price to Book
|
2.16
x
|
1.69
x
|
2.18
x
|
1.58
x
|
2.02
x
|
2.11
x
|
2.15
x
|
2.24
x
|
Nbr of stocks (in thousands)
|
405,800
|
417,305
|
435,275
|
472,521
|
553,469
|
597,916
|
-
|
-
|
Reference price
2 |
81.78
|
64.62
|
85.77
|
65.55
|
90.17
|
104.0
|
104.0
|
104.0
|
Announcement Date
|
2/12/20
|
2/9/21
|
2/15/22
|
2/15/23
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,121
|
4,606
|
4,742
|
5,861
|
6,638
|
7,746
|
8,708
|
9,833
|
EBITDA
1 |
2,305
|
1,880
|
1,841
|
2,151
|
2,511
|
2,924
|
3,350
|
3,657
|
EBIT
1 |
1,278
|
841.3
|
803.3
|
841.1
|
1,110
|
1,317
|
1,637
|
1,778
|
Operating Margin
|
24.95%
|
18.27%
|
16.94%
|
14.35%
|
16.72%
|
17.01%
|
18.8%
|
18.08%
|
Earnings before Tax (EBT)
1 |
542.9
|
-31.55
|
170.8
|
173.1
|
350
|
781.2
|
1,061
|
1,240
|
Net income
1 |
1,232
|
978.8
|
336.1
|
141.2
|
340.1
|
752.3
|
1,057
|
1,253
|
Net margin
|
24.06%
|
21.25%
|
7.09%
|
2.41%
|
5.12%
|
9.71%
|
12.13%
|
12.74%
|
EPS
2 |
3.050
|
2.330
|
0.7800
|
0.3000
|
0.6600
|
1.305
|
1.743
|
2.030
|
Free Cash Flow
1 |
883.7
|
918.4
|
574.8
|
-
|
-
|
572.4
|
1,384
|
1,795
|
FCF margin
|
17.25%
|
19.94%
|
12.12%
|
-
|
-
|
7.39%
|
15.89%
|
18.26%
|
FCF Conversion (EBITDA)
|
38.34%
|
48.86%
|
31.22%
|
-
|
-
|
19.58%
|
41.31%
|
49.09%
|
FCF Conversion (Net income)
|
71.7%
|
93.83%
|
170.99%
|
-
|
-
|
76.1%
|
130.99%
|
143.28%
|
Dividend per Share
2 |
3.480
|
2.700
|
2.440
|
2.440
|
2.440
|
2.540
|
2.628
|
2.809
|
Announcement Date
|
2/12/20
|
2/9/21
|
2/15/22
|
2/15/23
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1,309
|
1,396
|
1,473
|
1,474
|
1,519
|
1,561
|
1,665
|
1,662
|
1,750
|
1,860
|
1,918
|
2,004
|
2,066
|
2,139
|
2,240
|
EBITDA
1 |
491
|
504.3
|
581.9
|
526.9
|
538.4
|
558.6
|
662.5
|
620.6
|
669.4
|
709.5
|
735
|
768.7
|
791.1
|
808.8
|
835.3
|
EBIT
1 |
206.5
|
200.2
|
271.6
|
173.2
|
196.1
|
219.5
|
320.6
|
281.3
|
288.6
|
343.6
|
338.6
|
354.1
|
380.1
|
402.3
|
-
|
Operating Margin
|
15.77%
|
14.35%
|
18.44%
|
11.75%
|
12.91%
|
14.06%
|
19.25%
|
16.93%
|
16.5%
|
18.48%
|
17.66%
|
17.67%
|
18.4%
|
18.81%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
38
|
152.3
|
72.24
|
87.46
|
140.9
|
217.3
|
233.8
|
255.5
|
251.1
|
272.2
|
Net income
1 |
58.67
|
61.92
|
89.78
|
-6.767
|
-3.728
|
25.67
|
103
|
127.5
|
83.91
|
127.1
|
197.9
|
218.8
|
221.2
|
242.2
|
260
|
Net margin
|
4.48%
|
4.44%
|
6.1%
|
-0.46%
|
-0.25%
|
1.64%
|
6.19%
|
7.67%
|
4.8%
|
6.84%
|
10.32%
|
10.92%
|
10.71%
|
11.32%
|
11.61%
|
EPS
2 |
0.1300
|
0.1400
|
0.2000
|
-0.0100
|
-0.0100
|
0.0500
|
0.2000
|
0.2400
|
0.1500
|
0.2200
|
0.3382
|
0.3653
|
0.3880
|
0.3925
|
0.4133
|
Dividend per Share
2 |
0.6100
|
0.6100
|
0.6100
|
0.6100
|
0.6100
|
-
|
0.6100
|
0.6100
|
0.6100
|
0.6100
|
0.6700
|
0.6700
|
0.6700
|
0.6584
|
0.6500
|
Announcement Date
|
2/15/22
|
5/10/22
|
8/9/22
|
11/7/22
|
2/15/23
|
5/2/23
|
7/31/23
|
10/30/23
|
2/13/24
|
4/29/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
15,003
|
12,196
|
13,862
|
13,916
|
13,742
|
13,901
|
14,352
|
15,236
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.51
x
|
6.488
x
|
7.53
x
|
6.468
x
|
5.472
x
|
4.754
x
|
4.284
x
|
4.167
x
|
Free Cash Flow
1 |
884
|
918
|
575
|
-
|
-
|
572
|
1,384
|
1,795
|
ROE (net income / shareholders' equity)
|
8.17%
|
6.21%
|
2%
|
0.74%
|
1.49%
|
2.72%
|
3.72%
|
4.35%
|
ROA (Net income/ Total Assets)
|
3.87%
|
2.97%
|
1%
|
0.39%
|
0.83%
|
1.6%
|
2.3%
|
2.8%
|
Assets
1 |
31,861
|
32,932
|
33,698
|
36,405
|
40,951
|
47,016
|
45,987
|
44,743
|
Book Value Per Share
2 |
37.90
|
38.30
|
39.40
|
41.40
|
44.70
|
49.30
|
48.30
|
46.40
|
Cash Flow per Share
2 |
3.800
|
3.270
|
2.990
|
2.860
|
3.090
|
3.570
|
4.390
|
4.590
|
Capex
1 |
652
|
446
|
701
|
1,108
|
1,533
|
1,051
|
1,071
|
929
|
Capex / Sales
|
12.74%
|
9.69%
|
14.77%
|
18.9%
|
23.09%
|
13.56%
|
12.3%
|
9.44%
|
Announcement Date
|
2/12/20
|
2/9/21
|
2/15/22
|
2/15/23
|
2/13/24
|
-
|
-
|
-
|
Average target price
108.3
USD Spread / Average Target +4.07% Consensus |
1st Jan change
|
Capi.
|
---|
| +15.38% | 62.21B | | +0.52% | 20.24B | | -0.76% | 13.83B | | +5.58% | 8B | | -3.95% | 6.25B | | +12.47% | 3.64B | | +0.14% | 3.31B | | -1.22% | 2.91B | | +18.96% | 2.89B | | -19.61% | 2.34B |
Healthcare REITs
|